Synapse - Jedd Wolchok

Results (26)

Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia

Journal Article

Smithy, J. W.; Pianko, M. J.; Maher, C.; Postow, M. A.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Wolchok, J. D.; Park, J. H.; Callahan, M. K.
Journal of Immunotherapy (2021)

Fulltext@MSK | Save

Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab

Journal Article

Postow, M. A.; Chasalow, S. D.; Kuk, D.; Panageas, K. S.; Cheng, M. L.; Yuan, J.; Wolchok, J. D.
Melanoma Research (2020)

Fulltext@MSK | Save

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma

Journal Article

Shoushtari, A. N.; Bluth, M. J.; Goldman, D. A.; Bitas, C.; Lefkowitz, R. A.; Postow, M. A.; Munhoz, R. R.; Buchar, G.; Hester, R. H.; Romero, J. A.; more...
Melanoma Research (2017)

Fulltext@MSK | Save

Efficacy and quality of life outcomes in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase 3 trial (CheckMate 067)

Meeting Abstract

Schadendorf, D.; Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; Taylor, F.; Sabater, J.; more...
Melanoma Research (2016)

Fulltext@MSK | Save

A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma

Journal Article

Shoushtari, A. N.; Ong, L. T.; Schoder, H.; Singh-Kandah, S.; Abbate, K. T.; Postow, M. A.; Callahan, M. K.; Wolchok, J.; Chapman, P. B.; Panageas, K. S.; more...
Melanoma Research (2016)

Fulltext@MSK | Save

Immune-priming of the tumor microenvironment by radiotherapy: Rationale for combination with immunotherapy to improve anticancer efficacy

Journal Article

Shahabi, V.; Postow, M. A.; Tuck, D.; Wolchok, J. D.
American Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Clinical trials remain essential to evaluate combination immunotherapies, and against a broader range of cancers

Journal Article

Wolchok, J.
Oncology Times (2013)

Fulltext@MSK | Save

Evaluating the safety of combined ipilimumab and radiotherapy for the treatment of metastatic melanoma

Meeting Abstract

Postow, M. A.; Barker, C. A.; Khan, S. A.; Wolchok, J. D.
Journal of Immunotherapy (2012)

Fulltext@MSK | Save

Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: How different are these from conventional treatment responses?